Malignant Solid Tumors

Oncology

5 drugs in development·4 companies·3 clinical trials

Drug Pipeline by Phase

Phase 3(2)

Drug	Company
tak-505	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-505	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)

Phase 1(2)

Drug	Company
gen1057	Genmab A/S (GMAB)
premedication	Genmab A/S (GMAB)

Phase 1/Phase 2(1)

Drug	Company
gen1057	GENMAB A/S (GNMSF)

BioSniper tracks 5 drugs in development for Malignant Solid Tumors across 4 companies.

There are 3 clinical trials targeting Malignant Solid Tumors tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.